BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7627975)

  • 21. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of two distinct alpha-(1-3)-L-fucosyltransferase activities in human colon carcinoma.
    Stroup GB; Anumula KR; Kline TF; Caltabiano MM
    Cancer Res; 1990 Nov; 50(21):6787-92. PubMed ID: 1698542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosyltransferases and glycosidases in Morris hepatomas.
    Bauer CH; Vischer P; Grünholz H; Reutter W
    Cancer Res; 1977 May; 37(5):1513-8. PubMed ID: 192453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection.
    Gorelik E; Xu F; Henion T; Anaraki F; Galili U
    Cancer Res; 1997 Jan; 57(2):332-6. PubMed ID: 9000578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of L-fucose and D-glucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and alpha-L-fucosidase activity in liver of diabetic rats.
    Wiese TJ; Dunlap JA; Yorek MA
    Biochim Biophys Acta; 1997 Apr; 1335(1-2):61-72. PubMed ID: 9133643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
    Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of fucosyltransferase and fucosidase inhibitors.
    Tu Z; Lin YN; Lin CH
    Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW; Leung SW; Chan CS; Yu MM; Wong YF
    Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
    Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
    J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha1,4-Fucosyltransferase activity in human serum and saliva.
    DeBose-Boyd RA; Nyame AK; Smith DF; Cummings RD
    Arch Biochem Biophys; 1996 Nov; 335(1):109-17. PubMed ID: 8914840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hydrolysis of L-fucose from some naturally occurring compounds by purified human-liver alpha-L-fucosidase.
    Thorpe R
    Carbohydr Res; 1978 Feb; 60(2):407-11. PubMed ID: 630552
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolism of a transformation-sensitive amino acid fucoside in normal and simian virus 40-transformed human embryonic lung cells.
    Steiner SM; Morton PA
    Cancer Res; 1984 Oct; 44(10):4476-9. PubMed ID: 6088040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Altered expression of Lewis antigens associated with malignant transformation in endometrial tissues].
    Inoue M; Sasagawa T; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1425-31. PubMed ID: 3049851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elevation of serum fucosyltransferase activities in malignant diseases--a sensitive tumor marker?].
    Amano N; Moriyama M; Hibi N; Tsukada Y
    Rinsho Byori; 1992 Feb; 40(2):182-8. PubMed ID: 1583792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of enzymatic synthesis and expression of Lewis determinants in human colorectal carcinoma.
    Fernández-Briera A; Cuevas E; Gil-Martín E
    Rev Esp Enferm Dig; 2015 Oct; 107(10):598-607. PubMed ID: 26437978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.